BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shih B, Brown JJ, Armstrong DJ, Lindau T, Bayat A. Differential gene expression analysis of subcutaneous fat, fascia, and skin overlying a Dupuytren's disease nodule in comparison to control tissue. Hand (N Y) 2009;4:294-301. [PMID: 19184239 DOI: 10.1007/s11552-009-9164-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wheeler HE, González-Neira A, Pita G, de la Torre-Montero JC, Alonso R, Lopez-Fernandez LA, Alba E, Martín M, Dolan ME. Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analyses. Pharmacogenet Genomics 2014;24:231-7. [PMID: 24595012 DOI: 10.1097/FPC.0000000000000037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
2 Shih B, Bayat A. Scientific understanding and clinical management of Dupuytren disease. Nat Rev Rheumatol 2010;6:715-26. [DOI: 10.1038/nrrheum.2010.180] [Cited by in Crossref: 101] [Cited by in F6Publishing: 67] [Article Influence: 9.2] [Reference Citation Analysis]
3 Shchudlo N, Varsegova T, Stupina T, Dolganova T, Shchudlo M, Shihaleva N, Kostin V. Assessment of palmar subcutaneous tissue vascularization in patients with Dupuytren’s contracture. World J Orthop 2018; 9(9): 130-137 [PMID: 30254969 DOI: 10.5312/wjo.v9.i9.130] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Skubitz KM. Biology and Treatment of Aggressive Fibromatosis or Desmoid Tumor. Mayo Clin Proc 2017;92:947-64. [PMID: 28578783 DOI: 10.1016/j.mayocp.2017.02.012] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
5 Misemer BS, Skubitz AP, Carlos Manivel J, Schmechel SC, Cheng EY, Henriksen JC, Koopmeiners JS, Corless CL, Skubitz KM. Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activity. Cancer Med 2014;3:81-90. [PMID: 24402778 DOI: 10.1002/cam4.160] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
6 Picardo NE, Khan WS. Advances in the understanding of the aetiology of Dupuytren's disease. Surgeon 2012;10:151-8. [PMID: 22297148 DOI: 10.1016/j.surge.2012.01.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
7 Sedic M, Pavelic SK, Hock K. Using functional genomics to identify drug targets: a Dupuytren's disease example. Methods Mol Biol 2012;910:15-31. [PMID: 22821590 DOI: 10.1007/978-1-61779-965-5_2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Tripoli M, Cordova A, Moschella F. Update on the role of molecular factors and fibroblasts in the pathogenesis of Dupuytren's disease. J Cell Commun Signal 2016;10:315-30. [PMID: 27271552 DOI: 10.1007/s12079-016-0331-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
9 Rehman S, Xu Y, Dunn WB, Day PJ, Westerhoff HV, Goodacre R, Bayat A. Dupuytren's disease metabolite analyses reveals alterations following initial short-term fibroblast culturing. Mol Biosyst 2012;8:2274-88. [PMID: 22772395 DOI: 10.1039/c2mb25173f] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
10 O'Gorman DB, Vi L, Gan BS. Molecular mechanisms and treatment strategies for Dupuytren's disease. Ther Clin Risk Manag 2010;6:383-90. [PMID: 20856684 DOI: 10.2147/tcrm.s9165] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Iqbal SA, Manning C, Syed F, Kolluru V, Hayton M, Watson S, Bayat A. Identification of mesenchymal stem cells in perinodular fat and skin in Dupuytren's disease: a potential source of myofibroblasts with implications for pathogenesis and therapy. Stem Cells Dev 2012;21:609-22. [PMID: 21612554 DOI: 10.1089/scd.2011.0140] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
12 Rödel F, Fournier C, Wiedemann J, Merz F, Gaipl US, Frey B, Keilholz L, Seegenschmiedt MH, Rödel C, Hehlgans S. Basics of Radiation Biology When Treating Hyperproliferative Benign Diseases. Front Immunol 2017;8:519. [PMID: 28515727 DOI: 10.3389/fimmu.2017.00519] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
13 Walker JT, McLeod K, Kim S, Conway SJ, Hamilton DW. Periostin as a multifunctional modulator of the wound healing response. Cell Tissue Res 2016;365:453-65. [PMID: 27234502 DOI: 10.1007/s00441-016-2426-6] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 10.4] [Reference Citation Analysis]
14 Cai L, Brophy RH, Tycksen ED, Duan X, Nunley RM, Rai MF. Distinct expression pattern of periostin splice variants in chondrocytes and ligament progenitor cells. FASEB J 2019;33:8386-405. [PMID: 30991832 DOI: 10.1096/fj.201802281R] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
15 Carvalhana G, Auquit-Auckbur I, Milliez PY. [Dupuytren's disease: state of knowledge and research in physiopathology]. Chir Main 2011;30:239-45. [PMID: 21592840 DOI: 10.1016/j.main.2011.03.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]